CL
TCON

CSS LLC’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

CSS LLC’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-2,261
Closed -$76K – 1152
2022
Q3 		$76K Buy
2,261
+1,005
+80% +$38.4K ﹤0.01% 846
2022
Q2 		$50K Sell
1,256
-150
-11% -$5.81K ﹤0.01% 947
2022
Q1 		$74K Buy
1,406
+468
+50% +$23.5K ﹤0.01% 971
2021
Q4 		$52K Buy
938
+193
+26% +$12.3K ﹤0.01% 1088
2021
Q3 		$58K Hold
745
– – ﹤0.01% 1047
2021
Q2 		$97K Hold
745
– – ﹤0.01% 940
2021
Q1 		$123K Buy
745
+695
+1,390% +$134K 0.01% 816
2020
Q4 		$12K Buy
+50
New +$6.96K ﹤0.01% 794

Other funds holding TCON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

CSS LLC's TCON Position: Q4 2022 in Review

CSS LLC sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q4 2022, closing a stake of 2,261 shares — an estimated $76K sold.

CSS LLC first reported a position in TCON in Q4 2020 and held it in 8 quarters. The position peaked at $123K in Q1 2021. 31 funds tracked by Wall St. Rank hold TCON as of Q4 2022.

  • CSS LLC reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • CSS LLC sold 2,261 TRACON Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $76K.
  • CSS LLC first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
  • CSS LLC's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $123K in Q1 2021.
  • 31 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on CSS LLC's 13F filing for Q4 2022, filed 14 Feb 2023.